These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10234539)

  • 1. Influence of formulation technique for hydroxypropyl-beta-cyclodextrin on the stability of aspirin in HFA 134a.
    Williams RO; Liu J
    Eur J Pharm Biopharm; 1999 Mar; 47(2):145-52. PubMed ID: 10234539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
    Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
    Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an ophthalmic formulation containing ciprofloxacin-hydroxypropyl-b-cyclodextrin complex.
    Nijhawan R; Agarwal SP
    Boll Chim Farm; 2003 Jun; 142(5):214-9. PubMed ID: 14526654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation, identification and inclusion actions of irisquinone hydroxypropyl-beta-cyclodextrin inclusion complex].
    Zhang XN; Yan XY; Tang LH; Gong JH; Zhang Q
    Yao Xue Xue Bao; 2005 Apr; 40(4):369-72. PubMed ID: 16011270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin.
    Gladys G; Claudia G; Marcela L
    Eur J Pharm Sci; 2003 Nov; 20(3):285-93. PubMed ID: 14592694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
    Williams RO; Mahaguna V; Sriwongjanya M
    Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moisture uptake and its influence on pressurized metered-dose inhalers.
    Williams RO; Hu C
    Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.
    Semcheddine F; Guissi Nel I; Liu X; Wu Z; Wang B
    AAPS PharmSciTech; 2015 Jun; 16(3):704-15. PubMed ID: 25511809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12).
    Ressing ME; Jiskoot W; Talsma H; van Ingen CW; Beuvery EC; Crommelin DJ
    Pharm Res; 1992 Feb; 9(2):266-70. PubMed ID: 1372732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an omeprazole parenteral formulation with hydroxypropyl-beta-cyclodextrin.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharm Dev Technol; 2007; 12(3):327-36. PubMed ID: 17613896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New injectable melphalan formulations utilizing (SBE)(7m)-beta-CD or HP-beta-CD.
    Ma DQ; Rajewski RA; Stella VJ
    Int J Pharm; 1999 Nov; 189(2):227-34. PubMed ID: 10536251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil citrate monohydrate-cyclodextrin nanosuspension complexes for use in metered-dose inhalers.
    Sawatdee S; Phetmung H; Srichana T
    Int J Pharm; 2013 Oct; 455(1-2):248-58. PubMed ID: 23876498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
    Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
    Fathy M; Sheha M
    Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
    McCormack B; Gregoriadis G
    Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.